Free press releases distribution network?

Agency / Source: 919 Marketing

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Cornerstone BioPharma J-Med Pharmaceuticals and Sovereign Pharmaceuticals Settle Pending Litigation - Cornerstone BioPharma of Cary, NC, and J-Med Pharmaceuticals of Boston, Ma, announced that they have settled pending patent litigation with Sovereign Pharmaceuticals, Ltd of Ft Worth, TX, in connection with US Patent No. 6,270,796 & AlleRx™ Dose Pack
Cornerstone BioPharma J-Med Pharmaceuticals and Sovereign Pharmaceuticals Settle Pending Litigation

 

PRZOOM - /newswire/ - Holly Springs, NC, United States, 2007/01/19 - Cornerstone BioPharma of Cary, NC, and J-Med Pharmaceuticals of Boston, Ma, announced that they have settled pending patent litigation with Sovereign Pharmaceuticals, Ltd of Ft Worth, TX, in connection with US Patent No. 6,270,796 & AlleRx™ Dose Pack.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Financial/Legal/Venture Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Cornerstone BioPharma, J-Med Pharmaceuticals and Sovereign Pharmaceuticals Settle Pending Litigation Concerning U.S. Patent No. 6,270,796 and AlleRx™ Dose Pack

Cornerstone BioPharma (“Cornerstone”) of Cary, North Carolina, and J-Med Pharmaceuticals (“J-Med”) of Boston, Massachusetts, today announced that they have settled pending patent litigation with Sovereign Pharmaceuticals, Ltd., (“Sovereign”) of Fort Worth, Texas, in connection with U.S. Patent No. 6,270,796 (“the ‘796 patent”). The litigation was brought by the patent owner J-Med and licensee Cornerstone, who markets and sells the AlleRx™ Dose Pack.

AlleRx™ Dose Pack is one of three respiratory focused brands in the Cornerstone product line. The AlleRx™ Dose Pack is a prescribed AM/PM dosing regimen, available in a 10-day and 30-day supply, indicated for relief of the symptoms of vasomotor rhinitis and allergic rhinitis (runny nose associated with high pollen counts and specific year-round allergens). Over 30 million people in the U.S. have been diagnosed with allergic rhinitis alone.

”Cornerstone is dedicated to the development and commercialization of niche respiratory products that serve both the healthcare professionals and their patients,” said Craig Collard, President and CEO of Cornerstone BioPharma. “We will continue to defend the licensed invention of the AlleRx™ Dose Pack against all infringers,” he added.

As part of the settlement, Sovereign entered into a consent judgment confirming the validity and enforceability of the ‘796 patent. Sovereign will cease manufacturing a product intended to be packaged in violation of the ‘796 patent. Sovereign has further agreed to a permanent injunction and admitted that the products they manufactured infringed the ‘796 patent. Cornerstone and J-Med have agreed to not pursue damages for Sovereign’s past infringement.

“The settlement and consent judgment entered by the Court confirm the validity and enforceability of J-Med’s ‘796 patent. With a substantial patent portfolio, J-Med remains dedicated to providing novel therapies to physicians and patients that significantly improve patient care,” said Allan Weinstein, M.D., President of J-Med Pharmaceuticals.

By agreement, Cornerstone, J-Med and Sovereign will make no further public announcements about the resolution of the litigation beyond these written statements.

About Cornerstone BioPharma

Cornerstone BioPharma, Inc. (cornerstonebiopharma.com), located next to North Carolina’s Research Triangle Park, is an emerging specialty pharmaceutical company that is currently focused on the development and commercialization of niche prescription medications in the respiratory arena. Cornerstone is actively engaged in strategic licensing of additional prescription products through acquisitions, strategic partnerships and new product development.

About J-Med

J-Med Pharmaceuticals is a 19-year-old intellectual property pharmaceutical company founded by physicians who invent, develop and patent pharmaceutical products and methods, primarily directed to the treatment of respiratory ailments. J-Med actively licenses its patents and patented technologies, and these patent-protected products are manufactured and sold throughout the United States.

About Sovereign

Sovereign Pharmaceuticals, established 1990, is a privately owned and operated company. Sovereign’s committed team of employees excels in cGMP training and is focused on delivering high quality products in a timely manner. During the past three years Sovereign has upgraded equipment and facilities to meet the demands of its customers. The firm has recently completed a major expansion of its Research and Development Department, moving that department to the state-of-the-art 7,200 square foot facility and employing several scientists and additional support personnel.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Financial/Legal/Venture Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: 919 Marketing

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Financial/Legal/Venture articles,
CATCH Visitors via Your Competitors Announcements!


Cornerstone BioPharma J-Med Pharmaceuticals and Sovereign Pharmaceuticals Settle Pending Litigation

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Mariana McCulley - 919Marketing.com 
919-459-8159 mmcculley[.]919marketing.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any 919 Marketing securities in any jurisdiction including any other companies listed or named in this release.

Financial/Legal/Venture via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From 919 Marketing / Company Profile


Read Financial/Legal/Venture Most Recent Related Press Releases:

Infinera to Participate in Upcoming Investor Conference
Propel Financial Services Partners with Clear Payment Solutions
Digital Payments Power Growth in Booming Asia-Pacific Financial Technology Landscape Notes Frost & Sullivan
Digital Readiness Key to Growth Opportunities in the Financial Services Market
Prairie Capital Advisors Announces The Sale of Cornerstone Treatment Facilities Network to An ESOP
Koch Agrees to Invest Over $2 Billion in Infor
FTI Consulting Recognized as a Top Service Provider in the Legal Industry
GE Completes Spin Off and Demerger of Bank BPH Core Bank to Alior Bank
ALM Expands Senior Leadership Team, Organization Focused on Customers and Transformation
Lazard Acquires Remaining 50% Stake in MBA Lazard - Fully Integrating its Latin American Operations

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today